Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

631 public trials 195 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Recruiting

A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of MK-6204 (SKB535) for Injection in Participants With Advanced Solid Tumors

NCT06726369

Conditions
Advanced Solid Tumors
Locations
  • Beijing Cancer Hospital Beijing, China
  • Hunan Cancer Hospital Changsha, China
  • West China Hospital of Sichuan University Chengdu, China
  • Chongqing University Cancer Hospital Chongqing, China
View Trial Details
Recruiting

Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors

NCT06819735

Conditions
Advanced Solid Tumors
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Macquarie University Clinical Trial Unit North Ryde, New South Wales, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
  • Peninsula & South Eastern Haematology & Oncology Group Frankston, Victoria, Australia
View Trial Details
Recruiting

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

NCT06413680

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +28 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • Yale School of Medicine North Haven, Connecticut, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Recruiting

A Study of MGC028 in Participants With Advanced Solid Tumors

NCT06723236

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +21 more
Locations
  • UCSF - Helen Diller Family Cancer Center San Francisco, California, United States
  • Mass General Brigham Boston, Massachusetts, United States
  • Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
View Trial Details

Related conditions